Fueling Innovation in Biotech and MedTech

Empowering cutting-edge companies worldwide to advance healthcare solutions

Strategic Capital for Science That Matters

We empower companies with the capital, service, mentorship, and networks to navigate the complex clinical R&D process.

Our mission is to guide groundbreaking ideas from concept to market and beyond.

Dr. Peter M. Kovacs in a suit and tie, wearing glasses, standing outdoors with blurred greenery and building in the background.

“Investment: important alone, but with the additional benefits coming from the expertise, the continuous professional support, and de-risking of the projects, it is a unique model.”

Bringing a life-saving innovation to the market isn't easy.

It’s a marathon filled with high costs, long timelines, and steep regulatory cliffs.

The Reality Check:

  • Success Rates: Only 1 in 10 clinical trial candidates receive FDA approval

  • Cost to Market: Over $2.6 billion, factoring in failures

  • Timeline: 10–15 years from preclinical to approval

You can’t do it alone. But you don’t have to.

Smart Capital Meets Deep Sector Expertise

Tailored Funding

We don't just write checks, we fund strategically, with your roadmap in mind.

Clinical R&D Guidance

Navigate trials with our team’s regulatory and scientific expertise.

Global Network Access

From key hires to strategic exits, we open the right doors.

Dr. Peter M. Kovacs in a navy suit and striped tie walking through a modern office building lobby with glass walls and a marble floor.

PMK-Ventures

  • Focused on early-stage Biotech & MedTech

  • Committed to long-term value creation, not just quick wins

  • Based in Singapore, with a global outlook

  • Backed by experts in clinical development, regulation, and commercialization